Ralf Rosskamp

2020

In 2020, Ralf Rosskamp earned a total compensation of $4.3M as Former Chief Medical Officer at Dicerna Pharmaceuticals, a 100% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$692,110
Option Awards$2,642,015
Salary$356,250
Stock Awards$625,490
Other$18,964
Total$4,334,829

Rosskamp received $2.6M in option awards, accounting for 61% of the total pay in 2020.

Rosskamp also received $692.1K in non-equity incentive plan, $356.3K in salary, $625.5K in stock awards and $19K in other compensation.

Rankings

In 2020, Ralf Rosskamp's compensation ranked 2,612th out of 13,090 executives tracked by ExecPay. In other words, Rosskamp earned more than 80.0% of executives.

ClassificationRankingPercentile
All
2,612
out of 13,090
80th
Division
Manufacturing
1,005
out of 5,618
82nd
Major group
Chemicals And Allied Products
372
out of 2,251
84th
Industry group
Drugs
320
out of 1,951
84th
Industry
Pharmaceutical Preparations
235
out of 1,456
84th

Pay ratio

Ralf Rosskamp's Pay$4,334,829
Median Employee's Pay$311,375
Pay Ratio

14

to 1

In 2020, the annual total compensation of Ralf Rosskamp was $4,334,829.

The annual total compensation of the median employee at Dicerna Pharmaceuticals was $311,375.

The ratio of Ralf Rosskamp's pay to the pay of median employee was therefore 14 to one.

Source: SEC filing on April 20, 2021.

Rosskamp's colleagues

We found six more compensation records of executives who worked with Ralf Rosskamp at Dicerna Pharmaceuticals in 2020.

2020

Douglas Fambrough

Dicerna Pharmaceuticals

Chief Executive Officer

2020

John Green

Dicerna Pharmaceuticals

Chief Financial Officer

2020

Bob Brown

Dicerna Pharmaceuticals

Chief Scientific Officer

2020

James Weissman

Dicerna Pharmaceuticals

Chief Operating Officer

2020

Shreeram Aradhye

Dicerna Pharmaceuticals

Chief Medical Officer

2020

Douglas Pagán

Dicerna Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like